| Aug 1 |
Pacira BioSciences, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
|
| Jul 31 |
Pacira (PCRX) Q2 Earnings Beat, Exparel Sales Drive Revenues
|
| Jul 31 |
Pacira BioSciences, Inc. (PCRX) Q2 2024 Earnings Call Transcript
|
| Jul 30 |
Pacira: Q2 Earnings Snapshot
|
| Jul 30 |
Pacira BioSciences Non-GAAP EPS of $0.89 beats by $0.19, revenue of $178M beats by $4.32M
|
| Jul 30 |
Pacira BioSciences Reports Second Quarter 2024 Financial Results
|
| Jul 29 |
Pacira BioSciences Q2 2024 Earnings Preview
|
| Jul 23 |
Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024
|
| Jul 23 |
Nanotechnology in medicine: Who are the leading public companies?
|
| Jul 17 |
Should Value Investors Buy Pacira BioSciences (PCRX) Stock?
|
